ABUS vs BABA
Arbutus Biopharma Corp (ABUS) versus Alibaba Group Holding Ltd (BABA) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Not investment advice. Open the ABUS and BABA stock pages for the full models.
Not investment advice.